Mechanistically, we proposed a model in which CBL0137 could induce cell cycle arrest by regulating the c-MYC/p53/p21 pathway and inhibiting NF-κB transcription of FACT, resulting in direct inhibition of cancer cell growth. Here, TP53 is linked to cancer.